Exogenous high-mobility group box 1 protein prevents postinfarction adverse myocardial remodeling through TGF-β/Smad signaling pathway

Journal of Cellular Biochemistry

Volumn 114, Issue 7, 2013, Pages 1634-1641

  He, Yiyu ^a,b   Zhou, Xiaoya ^a,b   Zheng, Xiaoxin ^a,b   Jiang, Xuejun ^a,b  

^a RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

^b WUHAN UNIVERSITY   (China)

Author keywords

HMGB1; MYOCARDIAL INFARCTION; SMAD; TGF

Indexed keywords

COLLAGEN TYPE 1; COLLAGEN TYPE 3; GELATINASE A; GELATINASE B; HIGH MOBILITY GROUP B1 PROTEIN; PHOSPHATE BUFFERED SALINE; SMAD PROTEIN; SMAD7 PROTEIN; SMALL INTERFERING RNA; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TISSUE INHIBITOR OF METALLOPROTEINASE 3; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY LIGATION; FIBROBLAST; HEART INFARCTION; HEART INFARCTION SIZE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART VENTRICLE REMODELING; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; SIGNAL TRANSDUCTION; UPREGULATION;

ANIMALS; BLOTTING, WESTERN; HMGB1 PROTEIN; MALE; MYOCARDIAL INFARCTION; RATS; RATS, SPRAGUE-DAWLEY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SMAD2 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; VENTRICULAR REMODELING;

EID: 84877722045     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.24505     Document Type: Article

References (21)

1. Andrassy M, Igwe J, Autschbach F, Volz C, Remppis A, Neurath MF, Schleicher E, Humpert PM, Wendt T, Liliensiek B, Morcos M, Schiekofer S, Thiele K, Chen J, Kientsch-Engel R, Schmidt AM, Stremmel W, Stern DM, Katus HA, Nawroth PP, Bierhaus A,. 2006. Posttranslationally modified proteins as mediators of sustained intestinal inflammation. Am J Pathol 169: 1223-1237. (Pubitemid 351194359)
2. Aukrust P, Gullestad L, Ueland T, Damas JK, Yndestad A,. 2005. Inflammatory and anti-inflammatory cytokines in chronic heart failure: Potential therapeutic implications. Ann Med 37: 74-85. (Pubitemid 40593279)
3. Eghbali M, Tomek R, Sukhatme VP, Woods C, Bhambi B,. 1991. Differential effects of transforming growth factor-beta 1 and phorbol myristate acetate on cardiac fibroblasts. Regulation of fibrillar collagen mRNAs and expression of early transcription factors. Circ Res 69: 483-490.
4. Erlandsson HH, Andersson U,. 2004. Mini-review: The nuclear protein HMGB1 as a proinflammatory mediator. Eur J Immunol 34: 1503-1512. (Pubitemid 39256031)
5. Kitahara T, Takeishi Y, Harada M, Niizeki T, Suzuki S, Sasaki T, Ishino M, Bilim O, Nakajima O, Kubota I,. 2008. High-mobility group box 1 restores cardiac function after myocardial infarction in transgenic mice. Cardiovasc Res 80: 40-46.
6. Lawrence DA,. 2001. Latent-TGF-beta: An overview. Mol Cell Biochem 219: 163-170.
7. Limana F, Germani A, Zacheo A, Kajstura J, Di Carlo A, Borsellino G, Leoni O, Palumbo R, Battistini L, Rastaldo R, Muller S, Pompilio G, Anversa P, Bianchi ME, Capogrossi MC,. 2005. Exogenous high-mobility group box 1 protein induces myocardial regeneration after infarction via enhanced cardiac C-kit+ cell proliferation and differentiation. Circ Res 97: e73-e83.
8. Limana F, Esposito G, D'Arcangelo D, Di Carlo A, Romani S, Melillo G, Mangoni A, Bertolami C, Pompilio G, Germani A, Capogrossi MC,. 2011. HMGB1 attenuates cardiac remodelling in the failing heart via enhanced cardiac regeneration and miR-206-mediated inhibition of TIMP-3. PLoS ONE 6: e19845.
9. Lotze MT, Tracey KJ,. 2005. High-mobility group box 1 protein (HMGB1): Nuclear weapon in the immune arsenal. Nat Rev Immunol 5: 331-342. (Pubitemid 40516158)
10. Matsui Y, Morimoto J, Uede T,. 2010. Role of matricellular proteins in cardiac tissue remodeling after myocardial infarction. World J Biol Chem 1: 69-80.
11. Park S, Yoon SJ, Tae HJ, Shim CY,. 2011. RAGE and cardiovascular disease. Front Biosci 16: 486-497.
12. Popovic PJ, DeMarco R, Lotze MT, Winikoff SE, Bartlett DL, Krieg AM, Guo ZS, Brown CK, Tracey KJ, Zeh HR,. 2006. High mobility group B1 protein suppresses the human plasmacytoid dendritic cell response to TLR9 agonists. J Immunol 177: 8701-8707. (Pubitemid 44893835)
13. Rahimi RA, Leof EB,. 2007. TGF-beta signaling: A tale of two responses. J Cell Biochem 102: 593-608. (Pubitemid 47557414)
14. Saltis J, Agrotis A, Bobik A,. 1996. Regulation and interactions of transforming growth factor-beta with cardiovascular cells: Implications for development and disease. Clin Exp Pharmacol Physiol 23: 193-200. (Pubitemid 26167427)
15. Schiller M, Javelaud D, Mauviel A,. 2004. TGF-beta-induced SMAD signaling and gene regulation: Consequences for extracellular matrix remodeling and wound healing. J Dermatol Sci 35: 83-92. (Pubitemid 38969031)
16. Takahashi K, Fukushima S, Yamahara K, Yashiro K, Shintani Y, Coppen SR, Salem HK, Brouilette SW, Yacoub MH, Suzuki K,. 2008. Modulated inflammation by injection of high-mobility group box 1 recovers post-infarction chronically failing heart. Circulation 118: 106-114.
17. Verrecchia F, Mauviel A,. 2002. Transforming growth factor-beta signaling through the Smad pathway: Role in extracellular matrix gene expression and regulation. J Invest Dermatol 118: 211-215. (Pubitemid 34158472)
18. Verrecchia F, Chu ML, Mauviel A,. 2001. Identification of novel TGF-beta/Smad gene targets in dermal fibroblasts using a combined cDNA microarray/promoter transactivation approach. J Biol Chem 276: 17058-17062.
19. Wang B, Omar A, Angelovska T, Drobic V, Rattan SG, Jones SC, Dixon IM,. 2007. Regulation of collagen synthesis by inhibitory Smad7 in cardiac myofibroblasts. Am J Physiol Heart Circ Physiol 293: H1282-H1290. (Pubitemid 47254231)
20. Werner F, Jain MK, Feinberg MW, Sibinga NE, Pellacani A, Wiesel P, Chin MT, Topper JN, Perrella MA, Lee ME,. 2000. Transforming growth factor-beta 1 inhibition of macrophage activation is mediated via Smad3. J Biol Chem 275: 36653-36658. (Pubitemid 32002067)
21. Xia Y, Lee K, Li N, Corbett D, Mendoza L, Frangogiannis NG,. 2009. Characterization of the inflammatory and fibrotic response in a mouse model of cardiac pressure overload. Histochem Cell Biol 131: 471-481.